Ceisteanna ar Pholasaí nó ar Reachtaíocht - Questions on Policy or Legislation
Dail Éireann — 2026-05-28
============================================================

Darren O'Rourke (SF), Meath East

Givinostat is a potentially life-altering drug for children with Duchenne muscular dystrophy. The European Commission granted conditional marketing authorisation for givinostat almost a year ago, on 6 June 2025. There has been a frustrating delay, some of it on the company's behalf. I understand that the HSE's drugs group will review givinostat at its June meeting and make a recommendation to the senior leadership team to approve the medicine or not. There is a campaign, Time is Muscle. Every day counts for these children. I ask that a decision be made as early as possible. Children need access to this drug.

---

Source: Houses of the Oireachtas. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). The Official Report is revised after first publication; the fetch timestamp below identifies the version quoted.

Record URI: https://data.oireachtas.ie/akn/ie/debateRecord/dail/2026-05-28/debate/main
Retrieved: 2026-09-21T01:01:08+00:00
Sitting date: 2026-05-28